Prognostic significance of the neutrophil/lymphocyte ratio in patients undergoing treatment with nivolumab for recurrent non-small-cell lung cancer

AIM: We investigated the prognostic potential of pretherapy measurement of the neutrophil/lymphocyte ratio (NLR) in patients (n = 56) with non-small-cell lung cancer deemed suitable for treatment with nivolumab. MATERIALS & METHODS: This was a multicenter, noninterventional, retrospective data a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rapoport, Bernardo L, Theron, Annette J, Vorobiof, Daniel A, Langenhoven, Lizanne, Hall, Jacqueline M, Van Eeden, Ronwyn I, Smit, Teresa, Chan, Sze-Wai, Botha, Michael C, Raats, Johann I, Necker, Margriet De, Anderson, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399612/
https://www.ncbi.nlm.nih.gov/pubmed/32774468
http://dx.doi.org/10.2217/lmt-2020-0014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399612/
https://www.ncbi.nlm.nih.gov/pubmed/32774468
http://dx.doi.org/10.2217/lmt-2020-0014

Ejemplares similares